Pregled bibliografske jedinice broj: 67276
Placental growth factor in healthy, diabetic and IUGR pregnancies
Placental growth factor in healthy, diabetic and IUGR pregnancies // Abstracts of the 17th European Congress of Perinatal Medicine ; u: Prenatal and Neonatal Medicine 5 (2000) / Di Renzo, Gian Carlo (ur.).
Huddersfield: The Parthenon Publishing Group, 2000. (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 67276 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Placental growth factor in healthy, diabetic and IUGR pregnancies
Autori
Đelmiš, J. ; Ivanišević, Marina ; Breyer, Darija ; Mayer, Davor
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the 17th European Congress of Perinatal Medicine ; u: Prenatal and Neonatal Medicine 5 (2000)
/ Di Renzo, Gian Carlo - Huddersfield : The Parthenon Publishing Group, 2000
Skup
European Congress of Perinatal Medicine (17 ; 2000)
Mjesto i datum
Porto, Portugal, 25.06.2000. - 28.06.2000
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
placental growth factor; insulin dependent diabetes mellitus; placenta
Sažetak
Angiogenesis and vascular transformation are important processes in the normal development of the placenta. Placental growth factor (PlGF) is a potent angiogenic growth factor and is thought to be important for placental development. THE AIM OF THE STUDY was to analyse PlGF levels throughout gestation and difference between three studied groups. MATERIAL AND METHODS: Serum samples were collected from (1) 24 healthy pregnant women throughout normal gestation, (2) 39 diabetic pregnant women throughout gestation, and (3) 10 pregnant women with IUGR from 34 weeks of gestation. Placenta growth factor levels were determined with an immunoassay. RESULTS: PlGF levels during normal and diabetic pregnancy increased from the 6th week of gestation to the 30th week. From 30 weeks' gestation PlGF subsequently declined to delivery (Figure). It was not found statistically significant difference in PlGF levels between healthy (123.4ą65.2) and diabetic pregnancy (163.6ą103.1 mg/L) at the time of the term delivery. Significantly less PlGF was found in pregnancies complicated by IUGR (89, 8ą33, 4 mg/L) when compared with healthy and diabetic pregnancies (p<0, 05). It was not found statistically significant correlation between birthweight and maternal levels of PlGF. CONCLUSION: PlGF levels are increased from the beginning of pregnancy to the late of second trimester in the groups of healthy and diabetic pregnant women ; after 30 weeks of gestation they subsequently declined to delivery. PlGF levels are significantly decreased in the maternal circulation in cases of pregnancies with IUGR. PlGF does not have a direct effect on fetal growth.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Napomena
Rad je kao predavaje prezentiran i na skupovima: a) 31st Annual Meeting of the European Association for the Study of Diabetes. Diabetic pregnancy study group, održanom od 22.-24.10.1999., Brijuni, Htvatska ; objavljen u Knjizi sažetaka ; b) 33rd Annual Meeting of the European association for the Study of Diabetes. Diabetic pregnancy study group, održanom od 13.-16.09.2001., Oxford, Engleska ; objavljen u Knjizi sazetaka, str. 53-53.
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb